Showing 1 - 2 results of 2 for search 'Nanette L. Douglas', query time: 0.02s Refine Results
  1. 1
    Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

    Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy by Zara A. Ioannides, Zara A. Ioannides, Zara A. Ioannides, Peter A. Csurhes, Peter A. Csurhes, Nanette L. Douglas, Nanette L. Douglas, Nanette L. Douglas, Gem Mackenroth, Gem Mackenroth, Gem Mackenroth, Andrew Swayne, Andrew Swayne, Andrew Swayne, Kate M. Thompson, Kate M. Thompson, Tracey J. Hopkins, Kerryn A. Green, Kerryn A. Green, Stefan Blum, Stefan Blum, Stefan Blum, Kaye D. Hooper, Kaye D. Hooper, Kaye D. Hooper, Kerstin H. Wyssusek, Kerstin H. Wyssusek, Alan Coulthard, Alan Coulthard, Michael P. Pender, Michael P. Pender

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

    Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis by Michael P. Pender, Peter A. Csurhes, Corey Smith, Nanette L. Douglas, Michelle A. Neller, Katherine K. Matthews, Leone Beagley, Sweera Rehan, Pauline Crooks, Tracey J. Hopkins, Stefan Blum, Kerryn A. Green, Zara A. Ioannides, Andrew Swayne, Blake T. Aftab, Kaye D. Hooper, Scott R. Burrows, Kate M. Thompson, Alan Coulthard, Rajiv Khanna

    Published 2020-10-01
    Get full text
    Article

Search Tools: